J2468 HCPCS Level II code: Injection, palonosetron hydrochloride (posfrea), 25 micrograms
J2468 is the HCPCS code for “Injection, palonosetron hydrochloride (posfrea), 25 micrograms” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms
Short description: Inj, palonosetron (posfrea)
HCPCS · United States
Medicare details
The indicators CMS publishes with J2468 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2024
Where J2468 sits
- 1J codesDrugs administered other than orally
- 2Active code J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2468 mean?
J2468 is the HCPCS code for “Injection, palonosetron hydrochloride (posfrea), 25 micrograms” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2468?
CMS lists J2468’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2468
All J codesJ2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mgJ2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mgJ2428Injection, paliperidone palmitate extended release (erzofri), 1 mgJ2430Injection, pamidronate disodium, per 30 mgJ2440Injection, papaverine hcl, up to 60 mgJ2460Injection, oxytetracycline hcl, up to 50 mgJ2469Injection, palonosetron hcl, 25 mcgJ2470Injection, pantoprazole sodium, 40 mgJ2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mgJ2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mgJ2501Injection, paricalcitol, 1 mcgJ2502Injection, pasireotide long acting, 1 mg